Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application
Authors
Keywords
Biomarkers, Cell-free DNA (cfDNA), Circulating tumour DNA (ctDNA), Liquid biopsy, Precision medicine
Journal
PANCREATOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-12-30
DOI
10.1016/j.pan.2020.12.017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics
- (2020) Musalula Sinkala et al. Scientific Reports
- Early detection of pancreatic cancer
- (2020) Stephen P Pereira et al. Lancet Gastroenterology & Hepatology
- Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients
- (2020) Nidhi Singh et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ctDNA monitoring using patient-specific sequencing and integration of variant reads
- (2020) Jonathan C. M. Wan et al. Science Translational Medicine
- Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
- (2020) Yoshiaki Nakamura et al. NATURE MEDICINE
- Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?
- (2019) Tamara M.H. Gall et al. Oncotarget
- Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer
- (2019) Xiaoyu Liu et al. EBioMedicine
- Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes
- (2019) Ines Santiago et al. INTERNATIONAL JOURNAL OF CANCER
- Multiplex Enrichment and Detection of Rare KRAS Mutations in Liquid Biopsy Samples using Digital Droplet Pre-Amplification
- (2019) Erica D. Pratt et al. ANALYTICAL CHEMISTRY
- Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
- (2019) Vincent P Groot et al. CLINICAL CANCER RESEARCH
- Genome-wide cell-free DNA fragmentation in patients with cancer
- (2019) Stephen Cristiano et al. NATURE
- Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
- (2019) Dominic G. Rothwell et al. NATURE MEDICINE
- Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood
- (2019) Maryam A. L. Eissa et al. Clinical Epigenetics
- Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
- (2019) B Lee et al. ANNALS OF ONCOLOGY
- Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma
- (2019) Marin Strijker et al. INTERNATIONAL JOURNAL OF CANCER
- Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing
- (2019) Naoyuki Iwahashi et al. Scientific Reports
- Perioperative dynamic changes in circulating tumor DNA in lung cancer patients (DYNAMIC)
- (2019) Kezhong Chen et al. CLINICAL CANCER RESEARCH
- Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
- (2019) Aparna R. Parikh et al. NATURE MEDICINE
- Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
- (2019) Makoto Sugimori et al. CANCER SCIENCE
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
- (2019) Pedram Razavi et al. NATURE MEDICINE
- Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer
- (2019) Sumitra Mohan et al. Scientific Reports
- KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients
- (2019) Zhe-Ying Wang et al. Frontiers in Oncology
- Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer
- (2019) Hitendra Patel et al. Journal of Hematology & Oncology
- KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study
- (2018) Yutaka Nakano et al. BRITISH JOURNAL OF CANCER
- Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer
- (2018) Mao Lin et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
- (2018) Oliver A. Zill et al. CLINICAL CANCER RESEARCH
- False positive plasma genotyping due to clonal hematopoiesis
- (2018) Yuebi Hu et al. CLINICAL CANCER RESEARCH
- Prognostic Implications of Multiplex Detection ofKRASMutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma
- (2018) Min Kyeong Kim et al. CLINICAL CHEMISTRY
- MutantKRASCirculating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring
- (2018) Ruth Perets et al. ONCOLOGIST
- Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma
- (2018) S. Manier et al. Nature Communications
- Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine
- (2018) Andrew J Aguirre et al. Cancer Discovery
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients
- (2018) Bente Risberg et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
- (2018) Sebastian Mueller et al. NATURE
- Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing
- (2018) Sabine Hellwig et al. PLoS One
- Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients
- (2018) Gahee Park et al. Scientific Reports
- Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
- (2018) Debang Li et al. BMC CANCER
- Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
- (2018) Vincent Bernard et al. GASTROENTEROLOGY
- Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
- (2018) Francesco Puleo et al. GASTROENTEROLOGY
- Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer
- (2018) Tao Wei et al. MOLECULAR CANCER THERAPEUTICS
- Current and future perspectives of liquid biopsies in genomics-driven oncology
- (2018) Ellen Heitzer et al. NATURE REVIEWS GENETICS
- Enhanced detection of circulating tumor DNA by fragment size analysis
- (2018) Florent Mouliere et al. Science Translational Medicine
- A Comparison of Cell-Free DNA Isolation Kits
- (2017) Laure Sorber et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA
- (2017) Paul Riviere et al. MOLECULAR CANCER THERAPEUTICS
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue
- (2017) Soichiro Ako et al. PANCREATOLOGY
- Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
- (2017) Joshua D. Cohen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct detection of early-stage cancers using circulating tumor DNA
- (2017) Jillian Phallen et al. Science Translational Medicine
- Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
- (2017) Viktor A. Adalsteinsson et al. Nature Communications
- Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer
- (2017) John H. Strickler et al. Cancer Discovery
- Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer
- (2017) Eveline E. Vietsch et al. Cancer Genetics
- Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer
- (2017) Andreas W. Berger et al. Oncotarget
- Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
- (2017) Patricia Adamo et al. Oncotarget
- Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma
- (2017) Stine Dam Henriksen et al. Oncotarget
- Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis
- (2017) Shivan Sivakumar et al. PLOS MEDICINE
- Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer
- (2017) Marzia Del Re et al. Scientific Reports
- Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer
- (2016) Naoto Hadano et al. BRITISH JOURNAL OF CANCER
- Origins, structures, and functions of circulating DNA in oncology
- (2016) A. R. Thierry et al. CANCER AND METASTASIS REVIEWS
- Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker
- (2016) Daniel Pietrasz et al. CLINICAL CANCER RESEARCH
- Detection ofKRASMutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer
- (2016) Nora Brychta et al. CLINICAL CHEMISTRY
- Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas
- (2016) Andreas W. Berger et al. GASTROENTEROLOGY
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Integrated digital error suppression for improved detection of circulating tumor DNA
- (2016) Aaron M Newman et al. NATURE BIOTECHNOLOGY
- Identification of tissue-specific cell death using methylation patterns of circulating DNA
- (2016) Roni Lehmann-Werman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer
- (2016) Jean-Luc Van Laethem et al. Targeted Oncology
- Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer
- (2016) Erina Takai et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma
- (2016) Stine Dam Henriksen et al. Clinical Epigenetics
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
- (2015) D. P. Steensma et al. BLOOD
- Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
- (2015) Jun Yu et al. GUT
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
- (2015) O. A. Zill et al. Cancer Discovery
- Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer
- (2015) Erina Takai et al. Scientific Reports
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation
- (2013) Maura Costello et al. NUCLEIC ACIDS RESEARCH
- Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
- (2013) Ellen Heitzer et al. Genome Medicine
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- Stromal biology and therapy in pancreatic cancer
- (2010) A. Neesse et al. GUT
- Methylation profile of circulating plasma DNA in patients with pancreatic cancer
- (2008) Anatoliy A. Melnikov et al. JOURNAL OF SURGICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started